Continuing Legal Education (CLE)

Home

 

 

In This Section

Free for Members: Design Patent Case Law Review: Federal Circuit, PTAB, and District Court

April 23, 2020 12:30 PM to 2:00 PM

Registration

Fee: Member-benefit exclusive!

Register Now

Member-benefit exclusive!  No CLE credit available. 

Join for a fast-paced overview of the most important design patent decisions from the Federal Circuit, the PTAB, and the district courts from the past year.  Hear from two prominent design patent IP thought leaders as they discuss the importance of these cases moving forward in 2020.

Presented by Tracy-Gene Durkin of Sterne Kessler PLLC; Christopher Carani of McAndrews, Held & Malloy, Ltd; Alex Neuworth of Foley & Lardner LLP; Pauline Pelletier of Sterne Kessler. PLLC; and Michael Piery of Quarles & Brady LLP


System requirements: 

Webinar access is compatible with any Windows 7 or later computer, Android OS devices, or Apple/iOS devices.  Check system compatibility here.

Accessibility for hearing impaired:

AIPLA’s webinars are available and accessible to individuals who are hearing impaired. If anyone at your location would like to know more about accommodations, please contact cle@aipla.org. We ask that you let us know at least 7 business days out from the webinar, to ensure that we can identify and deploy the solution that best fits our registrants needs.

 Disclaimer:  AIPLA is a nonprofit national bar association.  The sole purpose of this CLE program is to provide educational and informational content.  AIPLA does not provide legal services or advice.  The opinions, views and other statements expressed by contributors to this CLE program are solely those of the contributors.  These opinions, views and statements of the contributors do not necessarily represent those of AIPLA and should not be construed as such.




 

Add to:

 

 

News

  • AIPLA Comments on the Copyright Office's Proposed Fee Schedule Adjustment

    May 8, 2026

    Arlington, VA. May 1, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office’s Notice of Proposed Rulemaking on adjustments to its fee schedule.
  • TermDisc-Comments-March21-logo AIPLA Submits Comments on the Enlarged Board of Appeal’s 11 Preliminary Opinion in G 1/25

    May 1, 2026

    Arlington, VA. April 17, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the Enlarged Board of Appeal’s 11 March 2026 preliminary opinion in G 1/25, addressing whether patent descriptions must be adapted following claim amendments.
  • Supreme Court AIPLA Files Amicus Brief in Range of Motion Products, LLC v. Armaid Company Inc.

    April 20, 2026

    Arlington, VA — April 17, 2026 — The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the U.S. Court of Appeals for the Federal Circuit in Range of Motion Products, LLC v. Armaid Company Inc., No. 23-2427, supporting rehearing and rehearing en banc. AIPLA urges the Court to restore clarity to design patent law by (1) reaffirming that Gorham v. White (1871) provides the sole governing test for infringement and forecloses any separate “plainly dissimilar” threshold, and (2) confirming that claim construction may not be used to exclude any visual portions of the overall claimed design.
  • TermDisc-Comments-March21-logo AIPLA Comments on CNIPA Draft Measures for Prioritized Patent Examination

    April 1, 2026

    Arlington, VA. March 30, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the China National Intellectual Property Administration (CNIPA) regarding the Draft Measures for the Administration of Prioritized Examination of Patents.
  • AIPLA Files Amicus Brief in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc

    March 31, 2026

    Arlington, VA. March 27, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the Supreme Court in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889. AIPLA urges the Court to affirm the Federal Circuit’s application of the established Iqbal/Twombly pleading standard and inducement law in reviewing Hikma’s motion to dismiss Amarin’s claim that Hikma’s conduct, in combination with its “skinny label,” induced infringement of Amarin’s patented treatment methods.